Clinical Trial Update: Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I clinical trial of BC008-1A injection for advanced solid tumors is currently recruiting. The study includes patients with advanced esophageal cancer an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• BC008-1A

Snippet

Sponsor: Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | Conditions: Advanced Esophageal Cancers, Advanced Non-small Cell Lung Cancer (NSCLC) | Phase 1 | Status: RECRUITING